Latest News and Events

March 2016

February 2016

April 2014

Prof Martin Koltzenburg Joins Nanomerics Advisory Board

Nanomerics is pleased to announce the strengthening of its Scientific Advisory Board with the appointment of Professor Martin Koltzenburg.  

Professor Koltzenburg’s appointment will  support the clinical development of Nanomerics' lead product NM0127, a novel pain therapeutic based on an endogenous peptide.